Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysisToshi A. Furukawa, Georgia Salanti, Andrea Cipriani et al.|The Lancet Psychiatry|2019Cited by 318
Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysisAndrea Cipriani, Dan J. Stein, Taryn Williams et al.|Psychological Medicine|2017Cited by 154
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort studyRiccardo De Giorgi, Maxime Taquet, Ivan Koychev et al.|EClinicalMedicine|2024Cited by 59
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disordersRiccardo De Giorgi, Catherine J. Harmer, Amanda Adler et al.|Nature Mental Health|2025Cited by 58
No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic reviewToshi A. Furukawa, Andrea Cipriani, Philip J. Cowen et al.|Acta Psychiatrica Scandinavica|2019Cited by 27